Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acura Pharmaceuticals Inc (NASDAQ:ACUR)

2.69
Delayed Data
As of 3:59pm ET
 -0.2437 / -8.31%
Today’s Change
1.61
Today|||52-Week Range
6.75
+7.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.00123.0K751.0K8.6M
 
 
 
 
Cost of Goods Sold--114.0K0.00324.0K
 
 
 
Depreciation And Amortization131.0K134.0K274.0K332.0K
 
 
 
 
 
 
Operating ExpensesGross Income---125.0K477.0K7.9M
 
 
 
 
General Expenses9.6M13.7M12.5M11.6M
 
 
 
 
 
Other Operating Expenses0.00250.0K201.0K330.0K
 
 
 
 
Research And Development3.7M4.9M4.6M2.6M
 
 
 
 
 
Total Operating Expenses9.7M14.2M13.0M12.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.7M-14.1M-12.2M-4.0M
 
 
 
 
 
Interest Expense On Debt0.009.0K1.2M1.2M
 
 
 
 
Other Expenses-8.0K4.0K4.0K3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.7M-13.9M-13.2M-5.0M
 
 
 
 
 
Net Income-9.7M-13.9M-13.2M-5.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.5M9.6M9.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted9.5M9.6M9.8M12.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.00-$1.45-$1.35-$0.46
 
 
 
 
 
EPS Diluted-$1.00-$1.45-$1.35-$0.46